Rho Ventures V, L.P.

Rho Ventures V, L.P. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in NephroGenex, Inc., ReachLocal Inc and Advancis Pharmaceutical Corp. In total, 13 filings cover trades dated from 12 April 2007 to 6 January 2015.

The open-market side counts 2 purchases for €5.4M alongside 7 sales for €7.9M. Taken together, the sales exceed the purchases by €2.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. Since January 2015: no purchases and 3 sales on the market.

The newest entry dates from 6 January 2015: an open-market sale of €788k, in NephroGenex, Inc. The last insider purchase was made public on 25 May 2010, 5,996 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.